Regis Corp (RGS) CEO Susan Lintonsmith receives 12,125-share stock grant

Rhea-AI Filing Summary

Lintonsmith Susan reported acquisition or exercise transactions in this Form 4 filing.

REGIS CORP President and CEO Susan Lintonsmith received an equity grant of 12,125 shares of common stock. The shares were awarded at no cash cost and increase her direct holdings to 19,074 shares after the transaction. The award vests in three equal installments on the first, second, and third anniversaries of the grant date, contingent on her continued employment and other grant conditions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lintonsmith Susan

(Last) (First) (Middle)

3701 WAYZATA BOULEVARD

(Street)

MINNEAPOLIS MINNESOTA 55416

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
REGIS CORP [ RGS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/16/2026		A		12,125(1)	A	$0	19,074	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The award vests as to 1/3 of the shares on the first, second, and third anniversaries of the grant date, subject to the Reporting Person's continued employment with the Issuer through such anniversaries and the other terms and conditions of the grant agreements.

	/s/ Amy C. Seidel, by power of attorney	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did REGIS CORP (RGS) report for Susan Lintonsmith?

REGIS CORP reported that President and CEO Susan Lintonsmith received an award of 12,125 shares of common stock. This equity grant is compensation-related rather than an open-market purchase, increasing her direct holdings to 19,074 shares following the transaction.

Was Susan Lintonsmith’s REGIS CORP (RGS) Form 4 transaction a stock purchase or a grant?

The Form 4 shows a grant, not a purchase. Susan Lintonsmith received 12,125 shares of REGIS CORP common stock as a compensation award at a stated price of $0.00 per share, classified as a grant, award, or other acquisition.

How many REGIS CORP (RGS) shares does Susan Lintonsmith hold after this Form 4 grant?

After the reported grant, Susan Lintonsmith directly holds 19,074 shares of REGIS CORP common stock. This total reflects the addition of 12,125 awarded shares to her prior holdings, as disclosed in the Form 4 ownership table.

What is the vesting schedule for Susan Lintonsmith’s new REGIS CORP (RGS) stock award?

The 12,125-share award vests in three equal annual installments. One-third of the shares vest on each of the first, second, and third anniversaries of the grant date, subject to her continued employment and the other terms of the grant agreements.

Does the REGIS CORP (RGS) Form 4 indicate any stock option exercises for Susan Lintonsmith?

The Form 4 does not report any option exercises. It discloses only a non-derivative transaction classified as a grant, award, or other acquisition of 12,125 shares of common stock, with no derivative positions listed in the derivative transaction summary.